Arbutus Biopharma Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
15,464.20
14,953.00
24,873.00
1,491.00
10,700.00
5,945
SG&A Expense
27,004.50
47,396.00
61,243.00
68,691.00
78,805.00
73,954
EBIT
12,153.20
32,972.00
36,959.00
68,292.00
70,132.00
70,190
Unusual Expense
3,530.30
10,845.00
62,792.00
424,385.00
42,179.00
12,574
Non Operating Income/Expense
1,079.30
4,127.00
21,771.00
2,120.00
2,301.00
1,003
Interest Expense
-
-
-
-
261.00
226
Pretax Income
14,064.20
38,837.00
77,306.00
489,166.00
108,733.00
61,360
Income Tax
-
-
16,185.00
105,002.00
24,320.00
4,300
Consolidated Net Income
14,064.20
38,837.00
61,121.00
384,164.00
84,413.00
57,060
Net Income
14,064.20
38,837.00
61,121.00
384,164.00
84,413.00
57,060
Net Income After Extraordinaries
14,064.20
38,837.00
61,121.00
384,164.00
84,413.00
57,060
Net Income Available to Common
14,064.20
38,837.00
61,121.00
384,164.00
85,324.00
67,151
EPS (Basic)
0.92
1.80
1.34
7.24
1.56
1.21
Basic Shares Outstanding
15,302.70
21,603.10
45,462.30
53,074.40
54,723.30
55,304.10
EPS (Diluted)
0.92
1.80
1.34
7.24
1.56
1.21
Diluted Shares Outstanding
15,302.70
21,603.10
45,462.30
53,074.40
54,723.30
55,304.10
EBITDA
11,540.40
32,443.00
36,370.00
67,200.00
68,105.00
68,009
Non-Operating Interest Income
540.00
853.00
674.00
1,391.00
1,538.00
3,047
Preferred Dividends
-
-
-
-
911.00
10,091
About Arbutus Biopharma
View Profile
